  To review new developments in the medical and surgical treatment options for benign essential blepharospasm ( BEB). Botulinum<pathogen> toxin injections remain the mainstay treatment for BEB with several formulations currently commercially available. Reports in the medical literature support photochromatic modulation for the symptoms of photophobia<symptom> , as well as oral medications and surgical myectomy for control of the motor signs of eyelid protractor spasm. Although there remains no cure for BEB , several treatment options are available to effectively manage the signs and symptoms of the condition.